{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:11:39Z","timestamp":1793081499294,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M700080"],"award-info":[{"award-number":["2021M700080"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH302"],"award-info":[{"award-number":["ZR2020QH302"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902919"],"award-info":[{"award-number":["81902919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103912"],"award-info":[{"award-number":["82103912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.critrevonc.2022.103821","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T12:01:54Z","timestamp":1663588914000},"page":"103821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: Results from the Global Burden of Disease Study 2019"],"prefix":"10.1016","volume":"179","author":[{"given":"Yali","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.critrevonc.2022.103821_bib1","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/crj.12778","article-title":"Global trends in mortality from malignant mesothelioma: Analysis of WHO mortality database (1994\u20132013)","volume":"12","author":"Abdel Rahman","year":"2018","journal-title":"Clin. Respir. J."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103821_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/ijerph15030531","article-title":"Trends and the economic effect of asbestos bans and decline in asbestos consumption and production worldwide","volume":"15","author":"Allen","year":"2018","journal-title":"Int J. Environ. Res Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103821_bib3","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","article-title":"Epidemiology of mesothelioma in the 21(st) century in Europe and the United States, 40 years after restricted\/banned asbestos use","volume":"9","author":"Alpert","year":"2020","journal-title":"Transl. Lung Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103821_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/17512433.2022.2074835","article-title":"Splicing deregulation, microRNA and notch aberrations: fighting the three-headed dog to overcome drug resistance in malignant mesothelioma","volume":"15","author":"Anobile","year":"2022","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103821_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","article-title":"Malignant mesothelioma and its non-asbestos causes","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch. Pathol. Lab Med"},{"issue":"Suppl 5","key":"10.1016\/j.critrevonc.2022.103821_bib6","doi-asserted-by":"crossref","first-page":"v31","DOI":"10.1093\/annonc\/mdv199","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Baas","year":"2015","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103821_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/oemed-2019-105779","article-title":"Role of asbestos clearance in explaining long-term risk of pleural and peritoneal cancer: a pooled analysis of cohort studies","volume":"76","author":"Barone-Adesi","year":"2019","journal-title":"Occup. Environ. Med. (Lond., Engl. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103821_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00428-021-03031-7","article-title":"Pleural mesothelioma classification update","volume":"478","author":"Beasley","year":"2021","journal-title":"Virchows Arch."},{"issue":"142","key":"10.1016\/j.critrevonc.2022.103821_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1183\/16000617.0063-2016","article-title":"Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment","volume":"25","author":"Bibby","year":"2016","journal-title":"Eur. Respir. Rev."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103821_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00420-019-01433-4","article-title":"Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression","volume":"92","author":"Boffetta","year":"2019","journal-title":"Int Arch. Occup. Environ. Health"},{"issue":"52","key":"10.1016\/j.critrevonc.2022.103821_bib11","doi-asserted-by":"crossref","first-page":"33466","DOI":"10.1073\/pnas.2019652117","article-title":"Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma","volume":"117","author":"Bononi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2022.103821_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103698","article-title":"The application of cancer stem cell model in malignant mesothelioma","volume":"174","author":"Bronte","year":"2022","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103821_bib13","first-page":"402","article-title":"Mesothelioma: Scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"33","key":"10.1016\/j.critrevonc.2022.103821_bib14","doi-asserted-by":"crossref","first-page":"13618","DOI":"10.1073\/pnas.1105887108","article-title":"Erionite exposure in North Dakota and Turkish villages with mesothelioma","volume":"108","author":"Carbone","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10272","key":"10.1016\/j.critrevonc.2022.103821_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(21)00147-1","article-title":"Immune checkpoint inhibitors in mesothelioma: a turning point","volume":"397","author":"Ceresoli","year":"2021","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.critrevonc.2022.103821_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225664","article-title":"Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms","volume":"13","author":"Cersosimo","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103821_bib17","first-page":"1427","article-title":"Inhibition of human malignant pleural mesothelioma growth by mesenchymal stromal cells","volume":"10","author":"Cocc\u00e8","year":"2021","journal-title":"Cells (Basel, Switz. )"},{"key":"10.1016\/j.critrevonc.2022.103821_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fonc.2020.00187","article-title":"Immunotherapy in malignant pleural mesothelioma","volume":"10","author":"de Gooijer","year":"2020","journal-title":"Front Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103821_bib19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull. World Health Organ"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103821_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21037\/atm.2017.04.06","article-title":"The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad","volume":"5","author":"Emri","year":"2017","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.critrevonc.2022.103821_bib21","unstructured":"FDA: U.S. Food and Drug Administration. FDA Approves Drug Combination For Treating Mesothelioma. Press release. Available online: \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-drug-combination-treating-mesothelioma\u3009 (Accessed on 10th September 2022)."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103821_bib22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jtho.2018.04.023","article-title":"New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center","volume":"13","author":"Galateau","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103821_bib23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study","volume":"5","author":"Global Burden Of Disease Cancer Collaboration","year":"2019","journal-title":"Jama Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103821_bib24","first-page":"1237","article-title":"Ionizing radiation: a risk factor for mesothelioma","volume":"20","author":"Goodman","year":"2009","journal-title":"Cancer Cause Control"},{"key":"10.1016\/j.critrevonc.2022.103821_bib25","doi-asserted-by":"crossref","unstructured":"Hu, Y., Zhang, X., Zhang, A., Hou, Y., Liu, Y., Li, Q., 2021a, Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990\u20132019: Estimation based on Global Burden of Disease Study 2019. Hematol Oncol.","DOI":"10.21203\/rs.3.rs-508326\/v1"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103821_bib26","first-page":"1010","article-title":"Malignant mesothelioma: Advances in immune checkpoint inhibitor and mesothelin-targeted therapies","volume":"127","author":"Hu","year":"2021","journal-title":"Cancer-Am. Cancer Soc."},{"key":"10.1016\/j.critrevonc.2022.103821_bib27","unstructured":"Kazan-Allen L. Chronology of asbestos bans and restrictions. International Ban Asbestos Secretariat blog. Updated July 14, 2022. Available online: \u3008http:\/\/www.ibasecretariat.org\/chron_ban_list.php\u3009 (Accessed on 13th September 2022)."},{"issue":"2018","key":"10.1016\/j.critrevonc.2022.103821_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2018.07.139","article-title":"Familial risk of pleural mesothelioma increased drastically in certain occupations: A nationwide prospective cohort study","volume":"103","author":"Kharazmi","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103821_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-0039-1693406","article-title":"Malignant Mesothelioma: Has Anything Changed?","volume":"40","author":"Kim","year":"2019","journal-title":"Semin Respir. Crit. Care Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103821_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neo.2021.11.013","article-title":"Spatiotemporal trends of the global burden of melanoma in 204 countries and territories from 1990 to 2019: Results from the 2019 global burden of disease study","volume":"24","author":"Li","year":"2021","journal-title":"Neoplasia"},{"issue":"9564","key":"10.1016\/j.critrevonc.2022.103821_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(07)60412-7","article-title":"Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis","volume":"369","author":"Lin","year":"2007","journal-title":"Lancet"},{"issue":"10258","key":"10.1016\/j.critrevonc.2022.103821_bib32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Murray","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103821_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/oemed-2017-104298","article-title":"Estimation of the global burden of mesothelioma deaths from incomplete national mortality data","volume":"74","author":"Odgerel","year":"2017","journal-title":"Occup. Environ. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103821_bib34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1289\/ehp.1002845","article-title":"Global magnitude of reported and unreported mesothelioma","volume":"119","author":"Park","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"9483","key":"10.1016\/j.critrevonc.2022.103821_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103821_bib36","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.21037\/jtd-20-2761","article-title":"Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature","volume":"13","author":"Schumann","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103821_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/19338244.2020.1747966","article-title":"MicroRNAs diagnostic and prognostic value as predictive markers for malignant mesothelioma","volume":"75","author":"Sturchio","year":"2020","journal-title":"Arch. Environ. Occup. Health"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103821_bib38","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2022.103821_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103639","article-title":"A systematic review and meta-analysis of trials assessing PD-1\/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma","volume":"172","author":"Tagliamento","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103821_bib40","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jtho.2021.05.015","article-title":"DNA methylation as a diagnostic biomarker for malignant mesothelioma: a systematic review and meta-analysis","volume":"16","author":"Vandenhoeck","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"24s","key":"10.1016\/j.critrevonc.2022.103821_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/fon.15.317","article-title":"Biomarkers and prognostic factors for malignant pleural mesothelioma","volume":"11","author":"Vigneri","year":"2015","journal-title":"Future Oncol. (Lond., Engl. )"},{"issue":"10258","key":"10.1016\/j.critrevonc.2022.103821_bib42","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2022.103821_bib43","doi-asserted-by":"crossref","unstructured":"Yang, X., Chen, H., Zhang, D., Shen, L., An, G., Zhao, S., 2021, Global magnitude and temporal trend of infective endocarditis, 1990\u20132019: results from the Global Burden of Disease Study. Eur J Prev Cardiol.","DOI":"10.1093\/eurjpc\/zwab184"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103821_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40364-021-00340-6","article-title":"Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia","volume":"9","author":"Yang","year":"2021","journal-title":"Biomark. Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103821_bib45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ijc.33617","article-title":"Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039","volume":"149","author":"Yu","year":"2021","journal-title":"Int J. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103821_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20360","article-title":"Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017","volume":"4","author":"Zhai","year":"2021","journal-title":"JAMA Netw. Open"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822002451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822002451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:46:59Z","timestamp":1760903219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822002451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":46,"alternative-id":["S1040842822002451"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103821","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1361058\/v1","asserted-by":"object"}]},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: Results from the Global Burden of Disease Study 2019","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103821"}}